Comment; Tick-borne illnesses in general, Lyme in particular is such a complex disease, many forms of the pathogen, vectors, morphology changes, complex immune responses. We need more information!
- Jennifer Couzin-Frankel
See all authors and affiliationsScience 19 Apr 2019:
Vol. 364, Issue 6437, pp. 221
DOI: 10.1126/science.364.6437.221
You are currently viewing the summary.View Full Text
Summary
Months after a U.S. Congress–mandated advisory group sounded the alarm about tickborne illnesses and urged more federal action and money, the National Institutes of Health (NIH) is readying its first strategic plan for these diseases. Last week it also, serendipitously, issued a rare solicitation for prevention proposals in tickborne diseases. The new pot of money for those efforts, $6 million in 2020, represents a significant boost to the field; NIH spent $23 million on Lyme in 2018, by far the most common tickborne illness, with $56 million devoted to tickborne diseases overall. Cases of Lyme disease have roughly tripled since the 1990s, to more than 300,000, as ticks carrying the bacterium Borrelia burgdorferi have spread. Scientists still hope for more money for diagnostics and treatment research.
- COVID UPDATE: What is the truth? - 2022-11-08
- Pathologist Speaks Out About COVID Jab Effects - 2022-07-04
- A Massive Spike in Disability is Most Likely Due to a Wave of Vaccine Injuries - 2022-06-30
